An official website of the United States government
Gina S. Wei, M.D., M.P.H., is the Acting Deputy Director for Clinical Research and Strategic Initiatives at NHLBI. She also serves as the Institute's senior scientific advisor on Women's Health.
From December 2024 to May 2026, Dr. Wei was NHLBI’s Acting Director of the Division of Cardiovascular Science (DCVS), after serving as DCVS’ Associate Director of Prevention and Population Science since 2016. She has played important leadership roles in launching flagship initiatives in precision medicine, data science, population science, and women's health. Examples of these initiatives include NHLBI's Trans-Omics in Precision Medicine (TOPMed), BioData Catalyst, the Maternal Health Community Implementation Program, and the Multi-ethnic Observational Study of American Asian and Pacific Islander Communities (MOSAAIC), as well as the NIH All of Us Research Program and the NIH Implementing a Maternal health & PRegnancy Outcomes Vision for Everyone (IMPROVE) Initiative. For her exemplary scientific leadership and accomplishments, Dr. Wei has been recognized with multiple NHLBI Director's Awards, NIH Office of Director Honor Awards, and NIH Director's Awards.
Dr. Wei started her tenure at NHLBI as the Medical Officer of the Epidemiology branch in 2004. Prior to moving to NIH, she worked at the U.S. Food and Drug Administration. Dr. Wei earned her M.D. at George Washington University School of Medicine, her M.P.H. at the Uniformed Services University of Health Care Sciences, and her undergraduate degree in Biochemistry from the University of California at Los Angeles. She was a Fellow in General Internal Medicine and Chief Resident of Internal Medicine at the Washington Veterans Affairs Medical Center and a Resident in Internal Medicine in the Primary Care Track at the George Washington University School of Medicine.